taurine has been researched along with Colorectal Neoplasms in 12 studies
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to observe the impact of the mammalian sterile 20-like kinase 1-c-Jun N-terminal kinase (MST1-JNK) signaling pathway on apoptosis in colorectal cancer (CRC) cells induced by Taurine (Tau)." | 7.88 | Roles of the MST1-JNK signaling pathway in apoptosis of colorectal cancer cells induced by Taurine. ( Liu, L; Liu, Z; Tu, S; Wan, F; Wan, H; Xia, Y; Yu, B; Yu, L; Zhang, X; Zhu, W, 2018) |
| "The aim of this study was to observe the impact of the mammalian sterile 20-like kinase 1-c-Jun N-terminal kinase (MST1-JNK) signaling pathway on apoptosis in colorectal cancer (CRC) cells induced by Taurine (Tau)." | 3.88 | Roles of the MST1-JNK signaling pathway in apoptosis of colorectal cancer cells induced by Taurine. ( Liu, L; Liu, Z; Tu, S; Wan, F; Wan, H; Xia, Y; Yu, B; Yu, L; Zhang, X; Zhu, W, 2018) |
| "Although colorectal cancer (CRC) is considered one of the most preventable cancers, no non-invasive, accurate diagnostic tool to screen CRC exists." | 1.51 | Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer. ( Kim, ER; Kim, JJ; Kim, YH; Kwon, HN; Nam, H; Park, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CX | 1 |
| Wan, HF | 1 |
| Li, SY | 1 |
| Wan, FS | 1 |
| Wolf, PG | 1 |
| Cowley, ES | 1 |
| Breister, A | 1 |
| Matatov, S | 1 |
| Lucio, L | 1 |
| Polak, P | 1 |
| Ridlon, JM | 1 |
| Gaskins, HR | 1 |
| Anantharaman, K | 1 |
| Soetikno, R | 1 |
| Chiu, HM | 1 |
| Asokkumar, R | 1 |
| Sanduleanu, S | 1 |
| Tanaka, S | 1 |
| Rastogi, A | 1 |
| Uedo, N | 1 |
| Hammad, H | 1 |
| Triadafilopoulos, G | 1 |
| Liu, Z | 1 |
| Xia, Y | 1 |
| Zhang, X | 1 |
| Liu, L | 1 |
| Tu, S | 1 |
| Zhu, W | 1 |
| Yu, L | 1 |
| Wan, H | 1 |
| Yu, B | 1 |
| Wan, F | 1 |
| Kim, ER | 1 |
| Kwon, HN | 1 |
| Nam, H | 1 |
| Kim, JJ | 1 |
| Park, S | 1 |
| Kim, YH | 1 |
| Van den Hout, BM | 1 |
| Taal, BG | 3 |
| Gortzak, E | 1 |
| Zoetmulder, FA | 1 |
| Boot, H | 1 |
| ten Bokkel Huinink, WW | 2 |
| Rodenhuis, S | 1 |
| Smyth, JF | 1 |
| Hardcastle, JD | 1 |
| Denton, G | 1 |
| Alderson, D | 1 |
| Grace, RH | 1 |
| Mansi, JL | 1 |
| Yosef, HM | 1 |
| Nordle, O | 1 |
| Lauri, H | 1 |
| Wählby, S | 1 |
| Wils, J | 1 |
| McCourt, M | 1 |
| Wang, JH | 1 |
| Sookhai, S | 1 |
| Redmond, HP | 1 |
| Franklin, HR | 1 |
| McVie, JG | 1 |
| Gundersen, S | 1 |
| Dombernowsky, P | 1 |
| Cavalli, F | 1 |
| Bruntsch, U | 1 |
| Renard, J | 1 |
| Van Glabbeke, M | 1 |
| Pinedo, H | 1 |
2 trials available for taurine and Colorectal Neoplasms
| Article | Year |
|---|---|
Combination chemotherapy with tauromustine (TCNU), 5-fluorouracil and leucovorin in advanced colorectal carcinoma: a dose-finding study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dose-Response Rel | 1993 |
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; | 1995 |
10 other studies available for taurine and Colorectal Neoplasms
| Article | Year |
|---|---|
The inhibition of the invasion and metastasis of colorectal cancer cells by taurine through regulation of the PTEN/AKT/GSK-3β pathway.
Topics: Colorectal Neoplasms; Glycogen Synthase Kinase 3 beta; Humans; Proto-Oncogene Proteins c-akt; PTEN P | 2022 |
Diversity and distribution of sulfur metabolic genes in the human gut microbiome and their association with colorectal cancer.
Topics: Bacteria; Carcinoma; Colorectal Neoplasms; Gastrointestinal Microbiome; Humans; Sulfates; Sulfur; Ta | 2022 |
Use of the ACES (Appearance, Classification, Enhanced endoscopy, and Safe resection) algorithm for the recognition and management of malignant polyps-a letter in response to the Multi-Society Task Force on Colorectal Cancer recommendations.
Topics: Algorithms; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Endoscopy; Humans; Taurine | 2021 |
Roles of the MST1-JNK signaling pathway in apoptosis of colorectal cancer cells induced by Taurine.
Topics: Apoptosis; Caco-2 Cells; Cell Line, Tumor; Colorectal Neoplasms; Humans; MAP Kinase Signaling System | 2018 |
Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Alanine; Aminoisobutyric Acids; Biomarkers, Tumor; Colorect | 2019 |
Long-term survival in two cases of colorectal carcinoma following a new chemotherapy regimen and subsequent metastasectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; | 1995 |
TCNU in colorectal cancer. How many patients are needed to demonstrate that a drug doesn't work?
Topics: Antineoplastic Agents; Clinical Trials as Topic; Colorectal Neoplasms; Humans; Nitrosourea Compounds | 1996 |
Taurolidine inhibits tumor cell growth in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Anti-Infective Agents, Local; Cell Death; Cell Division; Cell Survival; Col | 2000 |
5-Fluorouracil plus tauromustine in advanced colorectal cancer: unexpected negative results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluoroura | 1990 |
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Humans; M | 1989 |